Year |
Citation |
Score |
2023 |
Melnick AF, Mullin C, Lin K, McCarter AC, Liang S, Liu YE, Wang Q, Jerome NA, Choe E, Kunnath N, Bodanapu G, Akter F, Magnuson B, Kumar S, Lombard DB, ... Muntean AG, et al. Cdc73 protects Notch-induced T-cell leukemia cells from DNA damage and mitochondrial stress. Blood. PMID 37616559 DOI: 10.1182/blood.2023020144 |
0.349 |
|
2022 |
Hu H, Saha N, Yang Y, Ahmad E, Lachowski L, Shrestha U, Premkumar V, Ropa J, Chen L, Teahan B, Grigsby S, Marschalek R, Nikolovska-Coleska Z, Muntean AG. The ENL YEATS epigenetic reader domain critically links MLL-ENL to leukemic stem cell frequency in t(11;19) Leukemia. Leukemia. PMID 36435883 DOI: 10.1038/s41375-022-01765-0 |
0.309 |
|
2021 |
Grigsby SM, Friedman A, Chase J, Waas B, Ropa J, Serio J, Shen C, Muntean AG, Maillard I, Nikolovska-Coleska Z. Elucidating the Importance of DOT1L Recruitment in MLL-AF9 Leukemia and Hematopoiesis. Cancers. 13. PMID 33562706 DOI: 10.3390/cancers13040642 |
0.372 |
|
2019 |
Ropa J, Saha N, Hu H, Peterson LF, Talpaz M, Muntean AG. SETDB1 mediated histone H3 lysine 9 methylation suppresses MLL-fusion target expression and leukemic transformation. Haematologica. PMID 31558673 DOI: 10.3324/haematol.2019.223883 |
0.419 |
|
2019 |
Saha N, Ropa J, Chen L, Hu H, Mysliwski M, Friedman A, Maillard I, Muntean AG. The PAF1c Subunit CDC73 Is Required for Mouse Hematopoietic Stem Cell Maintenance but Displays Leukemia-Specific Gene Regulation. Stem Cell Reports. PMID 31031188 DOI: 10.1016/J.Stemcr.2019.03.010 |
0.409 |
|
2019 |
Muntean AG, Ropa J, SAHA N, Hu H, Serio J, Zhao L, Basrur V, Nesvizhskii A, Maillard I. SETDB1 Mediated H3K9 Methylation Suppresses MLL-Fusion Target Expression and Leukemic Transformation Blood. 134: 110-110. DOI: 10.1182/Blood-2019-122610 |
0.491 |
|
2018 |
Ropa J, Saha N, Chen Z, Serio J, Chen W, Mellacheruvu D, Zhao L, Basrur V, Nesvizhskii AI, Muntean AG. PAF1 complex interactions with SETDB1 mediate promoter H3K9 methylation and transcriptional repression of and in acute myeloid leukemia. Oncotarget. 9: 22123-22136. PMID 29774127 DOI: 10.18632/Oncotarget.25204 |
0.35 |
|
2018 |
SAHA N, Ropa J, Chen L, Hu H, Mysliwski M, Friedman A, Maillard I, Muntean AG. The PAF1c Subunit Cdc73 Is Essential for Hematopoiesis and Displays Differential Gene Regulation in MLL-AF9 Driven Leukemia Blood. 132: 1280-1280. DOI: 10.1182/Blood-2018-99-118703 |
0.462 |
|
2018 |
Ropa J, SAHA N, Muntean AG. SETDB1 Represses Hox Gene Expression and Suppresses Acute Myeloid Leukemia Blood. 132: 1320-1320. DOI: 10.1182/blood-2018-99-117690 |
0.454 |
|
2017 |
Serio J, Ropa J, Chen W, Mysliwski M, Saha N, Chen L, Wang J, Miao H, Cierpicki T, Grembecka J, Muntean AG. The PAF complex regulation of Prmt5 facilitates the progression and maintenance of MLL fusion leukemia. Oncogene. PMID 28945229 DOI: 10.1038/onc.2017.337 |
0.395 |
|
2016 |
Chen L, Sun Y, Wang J, Jiang H, Muntean AG. Differential regulation of the c-Myc/Lin28 axis discriminates subclasses of rearranged MLL leukemia. Oncotarget. PMID 27007052 DOI: 10.18632/oncotarget.8199 |
0.338 |
|
2016 |
Serio J, Chen W, Mysliwski M, Chen L, Ropa J, Wang J, Muntean AG. The PAF Complex Regulation of Prmt5 Facilitates Leukemic Progression Blood. 128: 3914-3914. DOI: 10.1182/blood.V128.22.3914.3914 |
0.416 |
|
2015 |
Chen L, Chen W, Mysliwski M, Serio J, Ropa J, Abulwerdi FA, Chan RJ, Patel JP, Tallman MS, Paietta E, Melnick A, Levine RL, Abdel-Wahab O, Nikolovska-Coleska Z, Muntean AG. Mutated Ptpn11 alters leukemic stem cell frequency and reduces the sensitivity of acute myeloid leukemia cells to Mcl1 inhibition. Leukemia. 29: 1290-300. PMID 25650089 DOI: 10.1038/Leu.2015.18 |
0.428 |
|
2015 |
Chen L, Sun Y, Wang J, Jiang H, Muntean AG. Differential Regulation of c-Myc/Lin28 Discriminates Subclasses of Rearranged MLL Leukemia Blood. 126: 163-163. DOI: 10.1182/blood.V126.23.163.163 |
0.389 |
|
2014 |
Collins C, Wang J, Miao H, Bronstein J, Nawer H, Xu T, Figueroa M, Muntean AG, Hess JL. C/EBPα is an essential collaborator in Hoxa9/Meis1-mediated leukemogenesis. Proceedings of the National Academy of Sciences of the United States of America. 111: 9899-904. PMID 24958854 DOI: 10.1073/pnas.1402238111 |
0.329 |
|
2014 |
Chen L, Chen W, Mysliwski M, Serio J, Ropa J, Abulwerdi F, Chan RJ, Patel JP, Tallman MS, Paietta EM, Melnick AM, Levine RL, Abdel-Wahab O, Nikolovska-Coleska Z, Muntean AG. Hyperactive Ptpn11 Mutations Alters Leukemic Stem Cell Frequency through Mcl-1 Overexpression Blood. 124: 3565-3565. DOI: 10.1182/Blood.V124.21.3565.3565 |
0.419 |
|
2014 |
Rual JM, Xu T, Collins C, Zhang H, Wang J, Kuick R, Bronstein J, Basrur V, Park SS, Ha K, Chen L, Elenitoba-Johnson KS, Muntean AG, Hess JL. Characterization of the Molecular Interplay Between HOXA9 and Ogt in Leukemia Blood. 124: 3533-3533. DOI: 10.1182/blood.V124.21.3533.3533 |
0.447 |
|
2013 |
Muntean AG, Chen W, Jones M, Granowicz EM, Maillard I, Hess JL. MLL fusion protein-driven AML is selectively inhibited by targeted disruption of the MLL-PAFc interaction. Blood. 122: 1914-22. PMID 23900238 DOI: 10.1182/Blood-2013-02-486977 |
0.325 |
|
2012 |
Wang J, Muntean AG, Hess JL. ECSASB2 mediates MLL degradation during hematopoietic differentiation. Blood. 119: 1151-61. PMID 22174154 DOI: 10.1182/blood-2011-06-362079 |
0.405 |
|
2011 |
Tan J, Jones M, Koseki H, Nakayama M, Muntean AG, Maillard I, Hess JL. CBX8, a polycomb group protein, is essential for MLL-AF9-induced leukemogenesis. Cancer Cell. 20: 563-75. PMID 22094252 DOI: 10.1016/J.Ccr.2011.09.008 |
0.356 |
|
2010 |
Muntean AG, Tan J, Sitwala K, Huang Y, Bronstein J, Connelly JA, Basrur V, Elenitoba-Johnson KS, Hess JL. The PAF complex synergizes with MLL fusion proteins at HOX loci to promote leukemogenesis. Cancer Cell. 17: 609-21. PMID 20541477 DOI: 10.1016/J.Ccr.2010.04.012 |
0.311 |
|
2010 |
Wang J, Muntean AG, Hess JL. A Novel Ubiquitination Pathway Regulates MLL Activity During Hematopoietic Differentiation Blood. 116: 743-743. DOI: 10.1182/blood.v116.21.743.743 |
0.462 |
|
2007 |
Huang Z, Richmond TD, Muntean AG, Barber DL, Weiss MJ, Crispino JD. STAT1 promotes megakaryopoiesis downstream of GATA-1 in mice. The Journal of Clinical Investigation. 117: 3890-9. PMID 18060035 DOI: 10.1172/Jci33010 |
0.523 |
|
2007 |
Muntean AG, Pang L, Poncz M, Dowdy SF, Blobel GA, Crispino JD. Cyclin D-Cdk4 is regulated by GATA-1 and required for megakaryocyte growth and polyploidization. Blood. 109: 5199-207. PMID 17317855 DOI: 10.1182/Blood-2006-11-059378 |
0.558 |
|
2007 |
Muntean A, Pang L, Poncz M, Dowdy S, Blobel G, Crispino J. Cyclin D/CDK4/6 kinase activity, regulated by GATA1, is required for megakaryocyte polyploidization Blood Cells, Molecules, and Diseases. 38: 133. DOI: 10.1182/Blood.V108.11.780.780 |
0.586 |
|
2006 |
Muntean AG, Ge Y, Taub JW, Crispino JD. Transcription factor GATA-1 and Down syndrome leukemogenesis. Leukemia & Lymphoma. 47: 986-97. PMID 16840187 DOI: 10.1080/10428190500485810 |
0.551 |
|
2005 |
Muntean AG, Crispino JD. Differential requirements for the activation domain and FOG-interaction surface of GATA-1 in megakaryocyte gene expression and development. Blood. 106: 1223-31. PMID 15860665 DOI: 10.1182/Blood-2005-02-0551 |
0.57 |
|
Show low-probability matches. |